-
Connect 2 Cleanrooms and Elis Cleanroom announce partnership
europeanpharmaceuticalreview
May 24, 2019
Connect 2 Cleanrooms and Elis Cleanroom announce partnership.
-
Micro-Sphere partnership to further support the commercial needs of its customers
cphi-online
May 05, 2019
Customers will receive comprehensive support particularly at the critical phases of industrial scale-up, technology transfer and process validation.
-
BioInvent receives €0.75 M under Mitsubishi Tanabe Pharma partnership
biospectrumasia
April 28, 2019
The license agreement with Mitsubishi Tanabe Pharma covers the development of antibodies from the n-CoDeR antibody library.
-
CPhI NA Partners with iBIO
contractpharma
April 24, 2019
CPhI North America has formed a new partnership with Illinois Biotechnology Innovation Organization (iBIO). Through the partnership, CPhI North America will donate $10,000 to the iBIO EDUCATE Center
-
Charles River & CHDI Extend Partnership
contractpharma
April 15, 2019
Five-year extension of their ongoing collaboration that started in 2005 for the drug discovery and development for Huntington’s disease...
-
Laurus Labs enters into strategic partnership agreement with Global Fund
expressbpd
March 27, 2019
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
-
Natera and BGI Genomics announce $50M partnership
biospectrumasia
March 12, 2019
Natera, Inc. , a leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., the largest cell-free DNA clinical testing laboratory in China have announced a $50 million partnership to commercialize Natera's Signatera™ MRD test in China, and to d
-
BDI - Novartis partnership is announced
firstwordpharma
January 21, 2019
Novartis today announced a five-year collaboration with the Big Data Institute (BDI) to establish a world-leading research alliance that will improve drug development by making it more efficient and more targeted.
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
AstraZeneca boosts drug discovery through partnership
biospectrumasia
October 29, 2018
AstraZeneca boosts drug discovery through partnership